MNMD – mind medicine (mindmed) inc. - common shares (US:NASDAQ)
Stock Stats
News
MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock.
Why Mind Medicine Stock Is Soaring Today [Yahoo! Finance]
Form SCHEDULE 13G/A Mind Medicine (MindMed) Filed by: BlackRock, Inc.
Form 8-K Mind Medicine (MindMed) For: Jan 30
Form 8-K Mind Medicine (MindMed) For: Jan 10
Form 4 Mind Medicine (MindMed) For: Dec 26 Filed by: Barrow Robert
Form 4 Mind Medicine (MindMed) For: Dec 26 Filed by: Liao Carrie
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.